Evidence map›Paper›PMID 36716040›Full record

ArticleTranslational vision science & technology2023

Optimization and Validation of a Virtual Reality Orientation and Mobility Test for Inherited Retinal Degenerations.

Jean Bennett, Elena M Aleman, Katherine H Maguire, Jennifer Nadelmann, Mariejel L Weber, William M Maguire, Ayodele Maja, Erin C O'Neil, Albert M Maguire, Alexander J Miller and 1 more

Abstract read
In one paragraph

Article in Translational vision science & technology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Trial
  2. Review
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jean BennettScheie Eye Institute at the Perelman Center for Advanced Medicine, Philadelphia, PA, USA.
Elena M AlemanCenter for Advanced Retinal and Ocular Therapeutics at the University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
Katherine H MaguireCenter for Advanced Retinal and Ocular Therapeutics at the University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
Jennifer NadelmannScheie Eye Institute at the Perelman Center for Advanced Medicine, Philadelphia, PA, USA.
Mariejel L WeberScheie Eye Institute at the Perelman Center for Advanced Medicine, Philadelphia, PA, USA.
William M MaguireCenter for Advanced Retinal and Ocular Therapeutics at the University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
Ayodele MajaCenter for Advanced Retinal and Ocular Therapeutics at the University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
Erin C O'NeilCenter for Advanced Retinal and Ocular Therapeutics at the University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
Albert M MaguireScheie Eye Institute at the Perelman Center for Advanced Medicine, Philadelphia, PA, USA.
Alexander J MillerNeurology Virtual Reality Laboratory of the Department of Neurology, University of Pennsylvania, Philadelphia, PA, USA.
Tomas S AlemanScheie Eye Institute at the Perelman Center for Advanced Medicine, Philadelphia, PA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: To optimize a virtual reality (VR) orientation and mobility (O&M) test of functional vision in patients with inherited retinal degenerations (IRDs). Methods: We developed an O&M test using commercially available VR hardware and custom-generated software. Normally sighted subjects (n = 20, ages = 14-67 years) and patients with IRDs (n = 29, ages = 15-63 years) participated. Individuals followed a dim red arrow path to a "course exit," while trying to identify nine obstacles adjacent to, or directly in their path. Dark-adapted subjects completed 35 randomly selected VR courses at increasing luminances, twice per luminance step, binocularly, and uni-ocularly. Performance was graded automatically by the software. Patients with IRD completed a modified Visual Function Questionnaire (VFQ). Results: Normally sighted subjects identified approximately 50% of the obstacles at the dimmest course luminance. Except for two patients with IRD with poor vision, all patients were able to complete the test, although they required brighter (by >2 log units) luminances to identify 50% of the obstacles. In a single-luminance screening test in which normal subjects detected at least eight of nine objects, most patients with IRD underperformed; their performance related to disease severity, as measured by visual acuity, kinetic visual field extent, and VFQ scores. Test-retest differences in object detection were similar to the differences between the two eyes (±2 SD = ±2 objects). Conclusions: This VR-O&M test was able to distinguish subjects with IRDs from normal subjects reliably and reproducibly. Translational Relevance: This easily implemented, flexible, and objectively scored VR-O&M test promises to become a useful tool to assess the impact that IRDs and their treatments have on functional vision.

Indexed as

Retinal DegenerationVirtual RealityAdolescentAdultAgedHumansMiddle AgedVision, OcularVisual AcuityVisual FieldsYoung Adult

Identifiers

PMID36716040
PMCPMC9896841

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.